Clarithromycin

製品コードS2555 バッチS255503

印刷

化学情報

 Chemical Structure Synonyms A-56268 Storage
(From the date of receipt)
3 years -20°C powder
1 years -80°C in solvent
化学式

C38H69NO13

分子量 747.95 CAS No. 81103-11-9
Solubility (25°C)* 体外 DMSO (warmed with 50ºC water bath) 50 mg/mL (66.84 mM)
Water Insoluble
Ethanol Insoluble
体内 (毎回新しく調製した物を用意してください)
Homogeneous suspension
CMC-NA
≥5mg/ml Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.
Clear solution
5%DMSO 40%PEG300 5%Tween80 50%ddH2O

この製剤はselleckのラボで検証済みです。上記の溶解方法がご要望を満たさない場合、selleckの営業担当までお問い合わせ頂ければ、個別の試験を行います。

3mg/ml (4.01mM) Taking the 1 mL working solution as an example, add 50 μL of 60 mg/ml clarified DMSO stock solution to 400 μL of PEG300, mix evenly to clarify it; add 50 μL of Tween80 to the above system, mix evenly to clarify; then continue to add 500 μL of ddH2O to adjust the volume to 1 mL. The mixed solution should be used immediately for optimal results.
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

溶剤液(一定の濃度)を調合する

生物活性

製品説明 Clarithromycin (A-56268) is a macrolide antibiotic and a CYP3A4 inhibitor, used to treat a number of bacterial infections.
in vitro Clarithromycin suppresses this production in a dose-dependent manner in both monocytes and THP-1 cells. This compound regulates three other promoters that have either the NF-kappa B or the AP-1 binding sequences: two synthetic (pAP-1-Luc and pNF-kappa B-Luc) and one naturally occurring (ELAM-Luc). [1] It suppresses NF-kappaB activation induced by TNF-alpha in U-937 and Jurkat cells in a concentration-related manner. The chemical inhibits NF-kappaB activation induced by TNF-alpha in U-937, Jurkat, and A549 cells and PBMC and by SEA in PBMC. It prevents NF-kappaB-dependent reporter gene expression in U-937 cells. [2] This agent results in a significant suppression of production of each cytokine in 71% and a significant increase in 29% of the human monocytes. [3] It inhibits tumor necrosis factor (TNF)-alpha-induced IL-8 gene expression in a dose- and incubation time-dependent manner. This compound represses AP-1 binding in TNF-alpha-treated BET-1A cells. It represses IL-8 gene transcription mainly via the AP-1 binding site in human bronchial epithelial cells. [4] The substance suppresses IL-1 beta gene expression in human nasal epithelial cells stimulated by H. influenzae endotoxin (HIE). It suppresses intercellular adhesion molecule-1 gene expression in nasal fibroblasts stimulated by IL-1 beta. This chemical reduces DNA-binding activity of NF-kappa B in both human nasal epithelial cells and fibroblasts stimulated by HIE or IL-1 beta, respectively. [5]

プロトコル(参考用のみ)

参考

  • https://pubmed.ncbi.nlm.nih.gov/12003967/
  • https://pubmed.ncbi.nlm.nih.gov/11120942/
  • https://pubmed.ncbi.nlm.nih.gov/10221415/
  • https://pubmed.ncbi.nlm.nih.gov/10615065/
  • https://pubmed.ncbi.nlm.nih.gov/10646728/

Selleckの高級品が、幾つかの出版された研究調査結果(以下を含む)で使われた:

CAVIN1-Mediated hERG Dynamics: A Novel Mechanism Underlying the Interindividual Variability in Drug-Induced Long QT [ Circulation, 2024, 150(7):563-576] PubMed: 38682330
Activity of Drug Combinations against Mycobacterium abscessus Grown in Aerobic and Hypoxic Conditions [ Microorganisms, 2022, 10(7)1421] PubMed: 35889140
Integrated lipidomic and transcriptomic analysis reveals clarithromycin-induced alteration of glycerophospholipid metabolism in the cerebral cortex of mice [ Cell Biol Toxicol, 2021, 10.1007/s10565-021-09646-5] PubMed: 34458952
Clarithromycin synergizes with cisplatin to inhibit ovarian cancer growth in vitro and in vivo. [ J Ovarian Res, 2019, 12(1):107] PubMed: 31703731
Impact of Dynamically Exposed Polarity on Permeability and Solubility of Chameleonic Drugs Beyond the Rule of 5. [ J Med Chem, 2018, 61(9):4189-4202] PubMed: 29608068
Twenty-seven-nucleotide repeat insertion in the rplV gene confers specific resistance to macrolide antibiotics in Staphylococcus aureus [ Oncotarget, 2018, 9(40):26086-26095] PubMed: 29899844

長期の保管のために-20°Cの下で製品を保ってください。

人間や獣医の診断であるか治療的な使用のためにでない。

各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。